168 related articles for article (PubMed ID: 28426376)
21. Oral premalignant lesions: is a biopsy reliable?
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
J Oral Pathol Med; 2007 May; 36(5):262-6. PubMed ID: 17448135
[TBL] [Abstract][Full Text] [Related]
22. Use of carbon dioxide laser for the treatment of premalignant lesions of the oral mucosa.
Flynn MB; White M; Tabah RJ
J Surg Oncol; 1988 Apr; 37(4):232-4. PubMed ID: 3361914
[TBL] [Abstract][Full Text] [Related]
23. Nd:YAG and CO2 laser therapy of oral mucosal lesions.
White JM; Chaudhry SI; Kudler JJ; Sekandari N; Schoelch ML; Silverman S
J Clin Laser Med Surg; 1998 Dec; 16(6):299-304. PubMed ID: 10204434
[TBL] [Abstract][Full Text] [Related]
24. [Precancer stages of the oral mucosa: a review].
Dunsche A; Härle F
Laryngorhinootologie; 2000 Jul; 79(7):423-7. PubMed ID: 11005096
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
Sun Z; Gong Y; Huang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment of premalignant lesions of the oral mucosa.
Vedtofte P; Holmstrup P; Hjørting-Hansen E; Pindborg JJ
Int J Oral Maxillofac Surg; 1987 Dec; 16(6):656-64. PubMed ID: 3125262
[TBL] [Abstract][Full Text] [Related]
27. Use of antioxidant supplements in the treatment of human oral leukoplakia.
Kaugars GE; Silverman S; Lovas JG; Thompson JS; Brandt RB; Singh VN
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jan; 81(1):5-14. PubMed ID: 8850475
[TBL] [Abstract][Full Text] [Related]
28. Neodymium-YAG and CO2 lasers in treatment of pre-cancerous lesions of the oral cavity.
Gendelman H; Actis AB; Ouri HO
Acta Stomatol Belg; 1993 Jun; 90(2):95-101. PubMed ID: 8237638
[TBL] [Abstract][Full Text] [Related]
29. Cytologic and DNA-cytometric follow-up of oral leukoplakia after CO2- and Er:YAG-laser assisted ablation: a pilot study.
Schwarz F; Maraki D; Yalcinkaya S; Bieling K; Böcking A; Becker J
Lasers Surg Med; 2005 Jul; 37(1):29-36. PubMed ID: 15954115
[TBL] [Abstract][Full Text] [Related]
30. [Malignant progression of oral leukoplakia].
Inoue A; Uchida M; Kimura Y; Kazaoka N
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1650-6. PubMed ID: 2730062
[TBL] [Abstract][Full Text] [Related]
31. The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence.
Chandu A; Smith AC
Int J Oral Maxillofac Surg; 2005 Jun; 34(4):396-400. PubMed ID: 16053849
[TBL] [Abstract][Full Text] [Related]
32. [High concentrate A-mulsin, a new therapy concept in laryngeal leukoplakia].
Issing WJ; Struck R; Naumann A; Kastenbauer E
Laryngorhinootologie; 1996 Jan; 75(1):29-33. PubMed ID: 8851116
[TBL] [Abstract][Full Text] [Related]
33. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
34. Laser therapy decreases oral leukoplakia recurrence and boosts patient comfort: a network meta-analysis and systematic review.
Luo R; Wang Y; Li R; Ma Y; Chen H; Zhang J; Shen J
BMC Oral Health; 2024 Apr; 24(1):469. PubMed ID: 38632580
[TBL] [Abstract][Full Text] [Related]
35. Diode Laser in the Management of Leukoplakia - A Retrospective Study.
Shivhare P; Haidry N; Kumar A; Parihar A; Singh A; Subramanyam S
Ann Maxillofac Surg; 2022; 12(2):178-184. PubMed ID: 36874766
[TBL] [Abstract][Full Text] [Related]
36. Topical bleomycin for the treatment of dysplastic oral leukoplakia.
Epstein JB; Gorsky M; Wong FL; Millner A
Cancer; 1998 Aug; 83(4):629-34. PubMed ID: 9708924
[TBL] [Abstract][Full Text] [Related]
37. [Use of the carbon dioxide laser in the treatment of leukoplakia].
Gáspár L; Szabó G
Fogorv Sz; 1990 Mar; 83(3):65-9. PubMed ID: 2108879
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light.
Yu CH; Lin HP; Chen HM; Yang H; Wang YP; Chiang CP
Lasers Surg Med; 2009 Nov; 41(9):628-33. PubMed ID: 19816916
[TBL] [Abstract][Full Text] [Related]
39. Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.
Yang SW; Lee YS; Chang LC; Yang CH; Luo CM; Wu PW
Clin Oral Investig; 2021 Jun; 25(6):4045-4058. PubMed ID: 33411001
[TBL] [Abstract][Full Text] [Related]
40. [The use of CO2 laser in the treatment of leukoplakia of the oral cavity].
Betlejewski S; Winiarski P; Winiarska L
Otolaryngol Pol; 1997; 51 Suppl 25():109-12. PubMed ID: 9757672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
